3G1L | A:95-215 | ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND BDM14744 |
3G1M | A:95-215 | ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND BDM31381 |
3G1O | A:95-215 | ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND BDM14500 |
3O8G | A:95-215 | ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND BDM14801 |
3O8H | A:95-215 | ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH COMPOUND BDM14950 |
3SDG | A:98-214 | ETHIONAMIDE BOOSTERS PART 2: COMBINING BIOISOSTERIC REPLACEMENT AND STRUCTURE-BASED DRUG DESIGN TO SOLVE PHARMACOKINETIC ISSUES IN A SERIES OF POTENT 1,2,4-OXADIAZOLE ETHR INHIBITORS. |
3SFI | A:95-214 | ETHIONAMIDE BOOSTERS PART 2: COMBINING BIOISOSTERIC REPLACEMENT AND STRUCTURE-BASED DRUG DESIGN TO SOLVE PHARMACOKINETIC ISSUES IN A SERIES OF POTENT 1,2,4-OXADIAZOLE ETHR INHIBITORS. |
4DW6 | A:97-214 | NOVEL N-PHENYL-PHENOXYACETAMIDE DERIVATIVES AS POTENTIAL ETHR INHIBITORS AND ETHIONAMIDE BOOSTERS. DISCOVERY AND OPTIMIZATION USING HIGH-THROUGHPUT SYNTHESIS. |